EGFR mNSCLC: Challenges with Treatments in this Space
A panelist discusses how managing resistance mechanisms and toxicity profiles and identifying optimal sequencing strategies remain key challenges in treating EGFR-mutated metastatic non–small cell lung cancer despite advances in targeted therapies.
Recent Videos
Related Content
